Nanostring Technologies reported $-39716000 in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US USD 505M 65M
Becton, Dickinson and BDX:US USD 1.24B 11M
Bio Rad Laboratories BIO:US USD 125.04M 5.05M
Bruker BRKR:US USD 159.4M 5.5M
Catalent CTLT:US USD 242M 85M
Charles River Laboratories CRL:US USD 241.36M 15.77M
Danaher DHR:US USD 2.86B 306M
Exact Sciences EXAS:US USD -65936000 17.61M
Fluidigm FLDM:US USD -17992000 7.33M
Hologic HOLX:US USD 349.4M 64.4M
Illumina ILMN:US USD -58000000 407M
IQVIA Holdings Inc IQV:US USD 778M 54M
Mettler Toledo International MTD:US USD 372.1M 51.3M
Myriad Genetics MYGN:US USD -32300000 400K
Nanostring Technologies NSTG:US USD -39716000 6.42M
Perkinelmer PKI:US USD 283.64M 78.28M
Repligen RGEN:US USD 48.2M 16.34M
Roche Holding ROG:VX 10.43B 3B
Thermo Fisher Scientific TMO:US USD 2.77B 166M
Waters WAT:US USD 318.84M 94.62M